Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 or COVID‐19)

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 or COVID‐19) has been declared a pandemic by the World Health Organization and sent all countries scrambling to review emergency healthcare provisions. There is global evidence of each nation struggling to effectively manage the number of p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2020-10, Vol.22 (10), p.1942-1945
Hauptverfasser:	Khunti, Sachin, Khunti, Nitisha, Seidu, Samuel, Khunti, Kamlesh
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Brief Report Brief Reports Cardiovascular disease Cardiovascular Diseases - complications Cardiovascular Diseases - epidemiology Cardiovascular Diseases - therapy Chloroquine - therapeutic use Clinical Trials as Topic - methods Clinical Trials as Topic - standards Coronaviridae Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology COVID-19 - therapy Delivery of Health Care - methods Delivery of Health Care - standards Diabetes Endocrinology & Metabolism Female Glucocorticoids - therapeutic use Humans Hydroxychloroquine - therapeutic use Hypoglycemic Agents - therapeutic use Life Sciences & Biomedicine Male Metabolic Diseases - complications Metabolic Diseases - epidemiology Metabolic Diseases - therapy Metabolic syndrome Middle Aged Pandemics SARS-CoV-2 - physiology Science & Technology Severe acute respiratory syndrome coronavirus 2 type 2 diabetes Uncertainty
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!